Cooperation of the proapoptotic receptor agonist rhApo2L/TRAIL with the CD20 antibody rituximab against non-Hodgkin lymphoma xenografts. [electronic resource]
Producer: 20071226Description: 4037-46 p. digitalISSN:- 0006-4971
- Animals
- Antibodies, Monoclonal -- pharmacology
- Antibodies, Monoclonal, Murine-Derived
- Antibody Formation -- drug effects
- Antineoplastic Agents -- agonists
- Apoptosis -- drug effects
- Cell Line, Tumor
- Complement System Proteins -- metabolism
- Drug Resistance, Neoplasm -- drug effects
- Drug Synergism
- Female
- Humans
- Killer Cells, Natural -- metabolism
- Lymphocyte Depletion
- Lymphoma, Non-Hodgkin -- drug therapy
- Mice
- Mice, Inbred ICR
- Mice, SCID
- Receptors, TNF-Related Apoptosis-Inducing Ligand -- antagonists & inhibitors
- Receptors, Tumor Necrosis Factor -- antagonists & inhibitors
- Recombinant Proteins -- agonists
- Rituximab
- TNF-Related Apoptosis-Inducing Ligand -- agonists
- Transplantation, Heterologous
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.